Address key life science patent issues:  Protect innovation and maximise value 

Register your interest in the event now


Robust valuation and protection of intellectual property is critical to the success of pharmaceuticals and life sciences businesses at all stages of its development.  Leveraging your IP to protect your innovation and maximize value around the world is vital for biopharma and medtech companies, so finding successful strategies is paramount for patent practitioners.

Find out how to achieve this at the Life Sciences Patent Network event (October 2026), which brings together patent professionals from across Europe and America. By attending, you’ll join our growing network of leading patent attorneys for another jam-packed day of networking and learning .

With so many events in the calendar catering to either IP of the life sciences, this is the only event tailored specifically for patent lawyers specialising in the pharma/biotech/medtech industries.

Register your interest in LSPN Fall by entering your details on the form on the right >>

What sets LSPN North America–Fall apart from other industry events:

  • This isn’t a generic, catch-all IP event. Instead, it’s a targeted forum for patent professionals in the life sciences, gathering to delve into the core challenges of working within this field
  • Unlike other events in the industry we prioritise meeting and hearing from In-House professionals –  with at least 50% of our audience coming from a corporate background
  • Interactive sessions throughout culminating in our hugely popular roundtable discussions.

Enter your details and I’ll send you the agenda as soon as it is released>> 

For more information please contact:

Hannah Gore
Content Producer
World IP Review and Life Sciences IP Review Conferences 
Email: hgore@newtonmedia.co.uk
Tel: +44 (0) 203 301 8225


Register your interest now!  

Enter your details to register your interest for LSPN North America-Fall  and you’ll get updates on speakers, the agenda and discounts for attending.